Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Variantyx

Variantyx
2014 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$7M LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of whole genome sequencing platform intended to diagnose and generate clinical reports for rare inherited disorders. The company's platform simplifies sample collection, DNA extraction and sequencing, data analysis, interpretation and clinical reporting by automating them, enabling hospital and commercial labs to profitably expand their test menu with validated genomic diagnostic solutions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Decision/Risk Analysis
Other Healthcare Services
Primary Office
  • 1671 Worcester Road
  • Suite 300
  • Framingham, MA 01701
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Variantyx’s full profile, request a free trial.

Variantyx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 01-Jan-2019 $7M 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 00.00 00.00 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Variantyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Variantyx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Pitango Venture Capital Venture Capital Minority 000 0000 000000 0
20/20 HealthCare Partners Venture Capital Minority 000 0000 000000 0

Variantyx Executive Team (5)

Name Title Board
Seat
Contact
Info
Haim Neerman Co-Founder & Chief Executive Officer
Tomer Jackman Co-Founder & Chief Operating Officer
Noam Shomron Ph.D Chief Scientific Officer
Muthu Meyyappan Ph.D Chief Commercial Officer
Yaron Rachmany CIO

Variantyx Board Members (1)

Name Representing Role Since Contact
Info
Guy Ezekiel Ph.D Variantyx Board Member 000 0000